• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Device Problems Malposition of Device (2616); Material Split, Cut or Torn (4008)
Patient Problem Chest Pain (1776)
Event Type  Injury  
Manufacturer Narrative
As reported in a research article, over a period of 9 years 9,109 amplatzer devices were implanted, of those 19 were explanted.Five of the devices were explanted due to residual shunt; of these four had evidence of malposition of the device or a new atrial tear and two patients experienced chest pain.The results of the investigation are inconclusive since the devices were not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
Reference manufacturing report number:2135147-2019-00390, 2135147-2019-00389, 2135147-2019-00388, 2135147-2019-00386, 2135147-2019-00383, 2135147-2019-00382, 2135147-2019-00381.It was reported through a research article identifying amplatzer that may be related to explant of devices.Specific patient information is documented as unknown.Details are listed in the attached article, titled explantation of patent foramen ovale closure devices.A study was conducted on the explantation of patent foramen ovale (pfo) devices over a course of nine years.It was found that of the 9,109 amplatzer devices were implanted and 19 were explanted.Five of the devices that were explanted were due to residual shunts.Two of the patients experienced chest pains.There were indications of device malposition or new atrial tear in four of the patients.No patient consequences were reported post procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
pamela yip
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key9345063
MDR Text Key169321490
Report Number2135147-2019-00384
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,literatur
Reporter Occupation Physician
Type of Report Initial
Report Date 11/19/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/19/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received11/11/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
-
-